This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Abbott Laboratories (ABT) advanced 1.28% to $84.90 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&amp;P 500 Index rising 0.77% to 7,501.24 and the Dow Jones Industrial Average rising 0.75% to 50,063.46.
Abbott Laboratories closed 38.95% short of its 52-week high of $139.06, which the company reached on June 24th.
The stock outperformed some of its competitors Thursday, as Johnson &amp; Johnson (JNJ) rose 0.16% to $230.80, Pfizer Inc. (PFE) fell 0.81% to $25.75, and Merck &amp; Co. Inc. (MRK) fell 0.04% to $113.41.
Trading volume (10.9 M) remained 2.0 million below its 50-day average volume of 12.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 14, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-14-26 1636ET

ARKG

Abbott Laboratories (ABT) shares rose 1.28% to $84.90 on a strong trading day, outperforming competitors like Johnson & Johnson (JNJ) and Pfizer Inc. (PFE). The S&P 500 Index increased by 0.77%, while Abbott remains 38.95% below its 52-week high of $139.06. Trading volume was 10.9 million, below the 50-day average of 12.9 million. This information was generated by MarketWatch.

MarketWatch Automated

Abbott Laboratories

iShares Global Healthcare

VG Health

iShares US Medical Devices

Ark Genomic Revolution ETF

iShares US Pharma

Health Care Select Sector SPDR

SPDR S&P Health Equip

S&P 500

Dow Jones Industrial Average

Johnson & Johnson

Pfizer

Merck

Abbott Laboratories Stock Outperforms Competitors On Strong Trading Day